SCHEMBL20365010

SCHEMBL20365010

CC(=O)C1=CC=C(S(=O)(=O)N2CCC3(CC2)OCCN3C(=O)c2ccc(C(C)=O)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ TSHR P16473 2/20 0.36
▸ LMNA P02545 3/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ ACKR3 P25106 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ USP2 O75604 1/20 0.32
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12622116 0.82 ALDH1A1 (0.57) HTTKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL12622121 0.75 HTT (0.53) HTTKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL12655508 0.72 HTT (0.62) HTTKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL12625901 0.72 POLB (0.56) HTTKDM4EALDH1A1SMN1; SMN2TSHR
SCHEMBL12623924 0.71 HTT (0.49) HTTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL12622016 0.71 MAPK1 (0.46) HTTKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL12621830 0.69 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL13353201 0.69 LMNA (0.60) KDM4EALDH1A1SMN1; SMN2MAPTNPC1
SCHEMBL12626275 0.68 GPR119 (0.49) HTTKDM4ESMN1; SMN2NPC1LMNA
SCHEMBL12624085 0.67 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872899-B1 ALZHEIMER'S DISEASE ASSAY IN A LIVING PATIENT PAIN THERAPEUTICS INC (US) 2018-07-11 — — EP disclosed
Send feedback